Detall de l'activitat

XIVth Congress Catalan Society of Immunology (SCI). Joint meeting with European Federation of Immunological Societies on Tour (EFIS on TOUR)
Societat Catalana d'Immunologia
Dies 19 i 20 de novembre de 2020 | Online

Online

Online

Online

Dijous, 19 de novembre de 2020 | 15:30 - 20:15
15:30 - 16:00
Arrival, Registration and Documentation delivery > Online -
16:00 - 16:15
Welcome to the XIVth CONGRESS of the SCI > Online -
Presenten:
Marcos López Hoyos. President of the SEI
Ricardo Pujol Borrell. President of the SCI
16:15 - 17:00
Opening Lecture – > Online -
Immunological memory against the dogma
Ponent:
Andreas Radbruch. Charité, Universitätsmedizin Berlin
Moderador:
Pablo Engel Rocamora. University of Barcelona
17:00 - 17:30
Poster viewing > Online -
17:30 - 18:00
Plenary Session: Inter-TCR crosstalk during antigen recognition. > Online -
Moderador:
Annabel Valledor. University of Barcelona
Ponent:
Balbino Alarcón. Centro Biología Molecular Severo Ochoa, Madrid
18:00 - 19:45
Oral Communications, Session-1 – Basic and Experimental Immunology > Online -
Moderador:
Winfried Pickl. Medical University of Vienna
Experimental and genetic evidence for the involvement of CD6 in inflammatory bowel diseases.
Ponent:
Sergi Casadó Llombar. et al.
Macrophage mitochondrial MFN2 (mitofusin 2) links immune stress and immune response through reactive oxygen species (ROS) production
Ponent:
Antonio Celada. et al.
Immunomodulation of type 1 diabetes by 116C-NOD intestinal microbiota
Ponent:
Estela Rosell Mases. et al.
siRNA-containing transfection of vitamin D3-induced tolerogenic dendriticcells for the silencing of potential tolerogenic genes
Ponent:
Íñigo González Larreategui. et al.
Immunomodulatory properties of a soluble cytomegalovirus-encoded CD48 Homolog.
Ponent:
Francesc Poblador. et al.
MRL mice infected with cytomegalovirus (CMV) as an animal model of Sjögren’s Syndrome.
Ponent:
Joan Puñet Ortiz. et al.
HIV-1 enveloped Virus-Like Particles (VLP) displaying high density of HIV-1 Env-derived antigens on their surface induce a functional immune response beyond neutralizing activity
Ponent:
Ferran Tarrés Freixas. et al.
19:25 - 19:45
Discussion (Oral Communications, Session-1 – Basic and Experimental Immunology) > Online -
19:45 - 20:15
Plenary Session: The role of a new T helper cell type, Th-IL-2 cells, in allergic immune reactions > Online -
Moderador:
Eva Maria Martinez Carceres. Autonomus University of Barcelona
Ponent:
Winfried Pickl. Medical University of Vienna
Divendres, 20 de novembre de 2020 | 08:30 - 18:30
08:30 - 09:00
Arrival, Registration and Documentation delivery > Online -
09:00 - 09:30
Plenary Session: Tissue memory cells at the center of the immune system > Online -
Moderador:
Dolores Jaraquemada Perez de Guzmán. Autonomous University of Barcelona
Ponent:
René Van Lier. Sanquin Blood Supply. University of Amsterdam
09:30 - 10:00
Plenary Session: Development of humen “adaptive” NK cell populations: open issues. > Online -
Moderen:
Miguel López Botet. University Pompeu Fabra, Barcelona
Pablo Engel Rocamora. University of Barcelona
10:00 - 11:30
Oral Communications, Session 2: Clinical Immunology I > Online -
Moderen:
Cristina Costa Vallès. (IDIBELL, Barcelona
Mª Rosa Faner Canet. Hospital Clinic, Barcelona
Changes induced in lymphocyte subpopulations by dimethyl-fumarate treatment in multiple sclerosis could identify “NEDA” patients.
Ponent:
Aina Teniente Serra. et al.
Lymphocyte subpopulations analysis in psoriatic patients treated with biological drugs
Ponent:
Marc Boigues Pons. et al.
Myeloid-Derived Suppressor Cells in Kidney Transplant Recipients and the effect of Maintenance Immunotherapy
Ponent:
María Iglesias Escudero. et al.
Pretransplant adaptive NKG2C+ NK cells protect against cytomegalovirus infection in kidney transplant recipients
Ponent:
Michelle Ataya. et al.
Impaired lung NK activity in the lung of Idiopathic Pulmonary Fibrosis patients
Ponent:
Tamara Cruz. et al.
Immunophenotype in CU patients under omalizumab treatment.
Ponent:
Cristina Alejandra López Rodriguez
11:30 - 12:00
Plenary Session: Conventional and unconventional T cell response to microbial antigens. > Online -
Moderador:
Ricardo Pujol Borrell. Autonomous University of Barcelona
Ponent:
Federica Sallusto. Institute for Research in Biomedicine Bellinzona
12:00 - 13:00
Ordinary General Meeting- Societat Catalana d’Immunologia > Online -
13:00 - 13:30
Poster viewing > Online -
13:30 - 14:00
Lunch session sponsored by Becton Dickinson.Resolving immune cell identity one cell at time. The multiomic approach. > Online -
Ponent:
Werner Rodriguez. BD Biosciences | Single Cell Multiomics
14:30 - 16:15
Oral Communications, Session 3: Tumor Immunology and Immunotherapy > Online -
Moderador:
Manel Juan Otero. Hospital Clinic. Barcelona
Phase I multicenter clinical trial with chimeric antigen receptor with humanized anti-BCMA specific ( ARI0002h) in patients with relapsed or refractory multiple myeloma
Ponent:
Mariona Pascal Capdevila. et al.
CART19-BE-01: un ensayo académico Europeo sobre la administración de células CAR-T denominadas ARI-0001 en pacientes con trastornos linfoproliferativos CD19+.
Ponent:
Valentín Ortiz Maldonado. et al.
Humoral immune response in patients with CD19 positive relapsed/refractory B-cell malignances recruited into the CART19-BE-01 clinical trial
Ponent:
Ariadna Bartoló Ibars. et al.
Comparative analysis and characterization of TCR repertoires in breast cancer TILs
Ponent:
Andrea Aran Garriga. et al.
HAVCR2 mutations altering TIM-3 underlying hemophagocytic syndrome and subcutaneous panniculitis-like T-cell lymphoma.
Ponent:
Roger Colobran Oriol. et al.
Dynamics of T-cell subsets in non-small cell lung cancer patients treated with PD-1/PD-L1 axis blocking mAbs
Ponent:
Coral Zurera Egea. et al.
NK cell receptors and ligand variants modulate response to tyrosine kinaseinhibitors in patients with chronic myeloid leukemia
Ponent:
Laia Closa Gil. et al.
15:55 - 16:15
Discussion (Oral Communications, Session 3: Tumor Immunology and Immunotherapy) > Online -
16:15 - 16:45
Plenary Session: Unconventional receptor-based antibodies > Online -
Moderador:
Miguel López Botet. (University Pompeu Fabra , Barcelona
Ponent:
Antonio Lanzavecchia. National Institute of Molecular Genetics, Milan
16:45 - 18:00
Oral Communications, Session 4: COVID-19 > Online -
Moderador:
Silvia Vidal Alcorisa. Santa Creu i Sant Pau Hospital, Barcelona
Early S2-targeting and rapid development of neutralizing antibodies after SARS-CoV-2 infection.
Moderador:
Maria Luisa Rodriguez de la Concepción. et al.
Antigen-specific lymphocyte proliferation against SARS-CoV-2 in COVID patients with negative antibodies against the virus in serum
Ponent:
Marc Boigues Pons. et al.
Immunological Risk Profile in COVID-19, the Experience of a Single Academic Hospital in Catalonia.
Ponent:
Manuel Hernández González. et al.
Immunopathogenesis of COVID-19-related pediatric inflammatory multisystem syndrome: overlap with Kawasaki disease and identification of a distinct severe group
Ponent:
Ana Esteve Solé. et al.
Revealing protective T cell immune responses against SARS-CoV-2.
Ponent:
Judith Grau Expósito. et al.
Inborn errors and autoantibodies against type-I inteferons in patients with life-threatening COVID-19.
Ponent:
Roger Colobran Oriol. et al.
17:45 - 18:00
Discussion.(Oral Communications, Session 4: COVID-19) > Online -
18:00 - 18:15
Prize to the best communication and poster > Online -
Ponent:
Ricardo Pujol Borrell. (President of SCI
18:15 - 18:30
Closing of the Congress > Online -
Presentador:
Ricardo Pujol Borrell. (President of SCI